Delivra Health Brands Inc.
DHBUF
$0.1364
$0.00725.57%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 30.57% | -15.27% | 6.14% | 30.93% | -14.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.57% | -15.27% | 6.14% | 30.93% | -14.49% |
| Cost of Revenue | 50.01% | -12.01% | 30.38% | 10.34% | -32.83% |
| Gross Profit | 13.91% | -18.24% | -9.89% | 60.76% | 11.61% |
| SG&A Expenses | 24.17% | 25.21% | 21.74% | 11.18% | 20.57% |
| Depreciation & Amortization | -2.80% | -4.02% | -4.47% | -1.51% | -2.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.34% | 3.20% | 22.59% | 9.37% | -9.09% |
| Operating Income | -29.40% | -247.89% | -261.58% | 71.40% | -23.98% |
| Income Before Tax | -21.61% | -308.01% | 25,726.67% | 58.69% | -172.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.61% | -308.01% | 25,726.67% | 58.69% | -172.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.61% | -308.01% | 25,726.67% | 58.69% | -172.75% |
| EBIT | -29.40% | -247.89% | -261.58% | 71.40% | -23.98% |
| EBITDA | -93.83% | -113.04% | -97.01% | 149.50% | -171.95% |
| EPS Basic | -3.33% | -274.63% | 18,550.00% | 66.50% | -169.23% |
| Normalized Basic EPS | -3.57% | -287.18% | 78.92% | 66.13% | -319.61% |
| EPS Diluted | -3.33% | -274.63% | 18,550.00% | 63.00% | -181.45% |
| Normalized Diluted EPS | -3.57% | -287.18% | 78.92% | 75.00% | -366.67% |
| Average Basic Shares Outstanding | 17.90% | 19.00% | 23.71% | 23.75% | 4.96% |
| Average Diluted Shares Outstanding | 17.90% | 19.00% | 23.71% | 66.41% | -14.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |